NASDAQ:CRTX
Delisted
Cortexyme Inc. Stock News
$2.20
+0 (+0%)
At Close: Nov 04, 2022
Cortexyme Publishes Data on P. Gingivalis Ability to Infect Neurons, Drive Alzheimer’s-Like Pathology in the Journal of Alzheimer’s Disease
12:30pm, Wednesday, 06'th May 2020
Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering a novel, disease-modifying therapeutic approach to treat what it believes to be a key underlying cause of Alzheime
Cortexyme Appoints Caryn McDowell, J.D. as Chief Legal and Administrative Officer and Corporate Secretary
08:05pm, Thursday, 30'th Apr 2020
Cortexyme, Inc. (Nasdaq: CRTX), a biopharmaceutical company developing treatments for Alzheimer’s disease (AD) and other degenerative diseases, today announced Caryn McDowell, J.D. will join the com
Summit Financial Group Reports First Quarter 2020 Results
10:00am, Thursday, 30'th Apr 2020
MOOREFIELD, W.V., April 30, 2020 -- Summit Financial Group, Inc. (“Company” or “Summit”) (NASDAQ: SMMF) today reported first quarter 2020 net income of $4.51 million, or $0.35.
Further Metallurgical Test Work Continues to Add Improvements and Modeled Revenue Increases at Alpala
12:00pm, Wednesday, 29'th Apr 2020
Cornerstone Capital Resources Inc. (“Cornerstone” or “the Company”) (CGP.V) (GWN.F) (GWN.BE) (CTNXF) is pleased to announce the following update on the exploration program at its Cascabel copp
During Ramadan, our ritual of gathering won’t happen but our values of community remain
04:16pm, Friday, 24'th Apr 2020
This year, we plan on holding our prayers at home as a family and focusing on the blessings of health and wellness despite social distancing.
Cortexyme, Inc. (NASDAQ:CRTX) Position Increased by Bank of New York Mellon Corp
08:58am, Tuesday, 21'st Apr 2020
Bank of New York Mellon Corp boosted its holdings in Cortexyme, Inc. (NASDAQ:CRTX) by 180.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Comm
Cornerstone Reports Significant Increase in Online Learning as Organizations Transition to Remote Work Globally
12:00pm, Friday, 17'th Apr 2020
New data from the Cornerstone Institute for People Development reveals 27.5 million hours were spent on Cornerstone Learning in March 2020.
Cortexyme, Inc. (NASDAQ:CRTX) Short Interest Up 16.9% in March
09:02am, Friday, 17'th Apr 2020
Cortexyme, Inc. (NASDAQ:CRTX) saw a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 1,630,000 shares, a growth of 16.9% from the March 15
Bramaderos Au Cu Project, Ecuador – High-grade surface samples at Espiritu epithermal gold-silver target
12:00pm, Wednesday, 08'th Apr 2020
OTTAWA, April 08, 2020 -- Cornerstone Capital Resources Inc. (“Cornerstone” or “the Company”) (TSXV-CGP) (F-GWN) (B-GWN) (OTC-CTNXF) is pleased to provide an update on its.
Alpala Mineral Resource Estimate # 3 delivers significant tonnage conversion to Measured Category
12:00pm, Tuesday, 07'th Apr 2020
OTTOWA, April 07, 2020 -- Cornerstone Capital Resources Inc. (“Cornerstone” or “the Company”) (TSXV:CGP) (Frankfurt:GWN) (Berlin:GWN) (OTC:CTNXF) is pleased to announce the.
Cortexyme to Present at the LifeSci Capital Alpha Series Virtual Conference on April 9, 2020
12:30pm, Monday, 06'th Apr 2020
Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat what it believes to be a key underlying cause of Alzheimer
Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat Alzheimer’s and other degenerative diseases, today annou
Cornerstone Capital Resources Inc. (“Cornerstone” or “the Company”) (TSXV-CGP) (F-GWN) (B-GWN) (OTC-CTNXF) is pleased to provide an update on its Bramaderos gold and copper project in southern
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN) and Cortexyme (CRTX)
04:27pm, Wednesday, 25'th Mar 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Elanco Animal Health (ELAN) and Cortexyme (CRTX). Elanco Animal Health
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (NYSE: ELAN) and Cortexyme (NASDAQ: CRTX)
04:27pm, Wednesday, 25'th Mar 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Elanco Animal Health (
ELAN
–
Research Report
) and Cortexyme (
CRTX
–
Research Report
).
Elanco Animal Health (EL
